0001104659-25-095401 Sample Contracts

PRE-FUNDED COMMON STOCK PURCHASE WARRANT applied dna sciences, inc.
Security Agreement • October 1st, 2025 • Applied Dna Sciences Inc • Services-testing laboratories • New York

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_______________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the later of (i) the date that Stockholder Approval (as defined in the Purchase Agreement) is obtained and (ii) the date that the Subscription Amount (as defined in the Purchase Agreement) is delivered in transferrable form reasonably acceptable to the Company with good and marketable title and is free and clear of any security interests, pledges, liens, restrictions, claims or encumbrances of any kind (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Commo

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • October 1st, 2025 • Applied Dna Sciences Inc • Services-testing laboratories

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • October 1st, 2025 • Applied Dna Sciences Inc • Services-testing laboratories • New York

This Securities Purchase Agreement (this “Agreement”), including the Summary of Recent Developments set forth in Annex A and the Risk Factors set forth in Annex B, is dated as of September __, 2025, between Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

Executive Employment Agreement
Executive Employment Agreement • October 1st, 2025 • Applied Dna Sciences Inc • Services-testing laboratories • New York

This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made as of September 29th, 2025 (the “Effective Date”), by and between Applied DNA Sciences, Inc. a Delaware corporation (together with its successors and assigns, the “Company”), and Clay Shorrock (“Executive”).

STRATEGIC DIGITAL ASSETS SERVICES AGREEMENT
Strategic Digital Assets Services Agreement • October 1st, 2025 • Applied Dna Sciences Inc • Services-testing laboratories • New York

This STRATEGIC DIGITAL ASSETS SERVICES AGREEMENT (this “Agreement”), by and between Applied DNA Sciences, Inc., a Delaware corporation with its principal place of business at 50 Health Sciences Drive, Stony Brook, NY 11790 (“Client”), and Cypress LLC, a Puerto Rico limited liability company with its principal place of business at 2067 Calle Espana #4 San Juan, PR 00911 (“Services Provider”), is entered into as of September 29, 2025 (the “Effective Date”). Client and Services Provider are referred to individually as a “Party” and collectively as the “Parties.”

STRATEGIC ADVISOR AGREEMENT
Strategic Advisor Agreement • October 1st, 2025 • Applied Dna Sciences Inc • Services-testing laboratories • New York

This STRATEGIC ADVISOR AGREEMENT (this “Agreement”) by and between Applied DNA Sciences, Inc., a Delaware corporation with its principal place of business at 50 Health Sciences Drive Stony Brook, NY 11790 (“Customer”), and Cypress Management LLC, a Puerto Rico limited liability company with its principal place of business at 2067 Calle Espana #4 San Juan, PR 00911 (“Advisor”), is entered into as of September 29, 2025 (the “Effective Date”). Customer and Advisor are referred to individually as a “Party” and collectively as the “Parties.”

Executive Officer Transition and Separation Agreement
Executive Officer Transition and Separation Agreement • October 1st, 2025 • Applied Dna Sciences Inc • Services-testing laboratories

THIS EXECUTIVE OFFICER transition and SEPARATION AGREEMENT (the “Separation Agreement”) is made and entered into and is effective as of this 29th day of September, 2025 (the “Effective Date”) by and between Applied DNA Sciences, Inc. (herein the “Employer” or “Company”) and Judith Murrah (herein “Employee”) and for good and valuable consideration including the mutual covenants contained herein, Employer and Employee agree as follows: